{"entity":{"type":"insider","cik":"0001717441","url":"/insider/0001717441","json_url":"/insider/0001717441.json","name":"Sukhtian Ghiath M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2021-02-02","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Sukhtian Ghiath M.","source":"filing","n_filings":4,"first_seen":"2021-02-02","last_seen":"2026-08-14"}],"transactions":[{"id":9204140,"accession":"0000899140-26-000894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899140-26-000894","line_url":"/filing/0000899140-26-000894#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":null,"owner_name":"GMS Ventures & Investments; Sukhtian Ghiath M.","owner_display_name":"GMS Ventures & Investments","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2525252.0,"shares_display":"2,525,252","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":2499999.48,"total_display":"2,499,999.48","total_whole":"2,499,999","shares_owned_after":24617320.0,"shares_owned_after_display":"24,617,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":6164026,"accession":"0000899140-26-000620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899140-26-000620","line_url":"/filing/0000899140-26-000620#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":null,"owner_name":"GMS Ventures & Investments; Sukhtian Ghiath M.","owner_display_name":"GMS Ventures & Investments","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8539709.0,"shares_display":"8,539,709","price_per_share":0.5855,"price_display":"0.59","price_state":"stated","total_value":4999999.6195,"total_display":"4,999,999.62","total_whole":"5,000,000","shares_owned_after":22092068.0,"shares_owned_after_display":"22,092,068","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-06-01","scope":"insider"},{"id":5457142,"accession":"0000947871-21-001250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-001250","line_url":"/filing/0000947871-21-001250#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":null,"owner_name":"Sukhtian Ghiath M.; GMS Ventures & Investments","owner_display_name":"Sukhtian Ghiath M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000000.0,"shares_display":"16,000,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":27834257.0,"shares_owned_after_display":"27,834,257","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":4511174,"accession":"0000947871-21-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-000128","line_url":"/filing/0000947871-21-000128#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":null,"owner_name":"Sukhtian Ghiath M.; GMS Ventures & Investments","owner_display_name":"Sukhtian Ghiath M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8360000.0,"shares_display":"8,360,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":8360000.0,"total_display":"8,360,000.00","total_whole":"8,360,000","shares_owned_after":10820630.0,"shares_owned_after_display":"10,820,630","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649989","name":"Outlook Therapeutics, Inc.","url":"/issuer/0001649989","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2021-02-02","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001717441","retrieved_at":"2026-08-22T17:11:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}